PMAQX
Price
$46.78
Change
-$0.35 (-0.74%)
Updated
Sep 25 closing price
Net Assets
33B
VRMGX
Price
$63.46
Change
-$0.61 (-0.95%)
Updated
Sep 25 closing price
Net Assets
940.98M
Interact to see
Advertisement

PMAQX vs VRMGX

Header iconPMAQX vs VRMGX Comparison
Open Charts PMAQX vs VRMGXBanner chart's image
Principal MidCap R6
Price$46.78
Change-$0.35 (-0.74%)
VolumeN/A
Net Assets33B
Virtus KAR Mid-Cap Growth R6
Price$63.46
Change-$0.61 (-0.95%)
VolumeN/A
Net Assets940.98M
PMAQX vs VRMGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMAQX vs. VRMGX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Hold and VRMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. VRMGX (941M). PMAQX pays higher dividends than VRMGX: PMAQX (0.18) vs VRMGX (0.00). PMAQX was incepted earlier than VRMGX: PMAQX (9 years) vs VRMGX (8 years). VRMGX (0.92) is less costly to investors than PMAQX (0.59). VRMGX is a more actively managed with annual turnover of: 13.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than VRMGX: PMAQX (0) vs VRMGX (2500000). PMAQX annual gain was more profitable for investors over the last year : 3.77 vs. VRMGX (1.73). PMAQX return over 5 years is better than : 51.10 vs. VRMGX (8.43).
PMAQXVRMGXPMAQX / VRMGX
Total Expense Ratio0.590.8371%
Annual Report Gross Expense Ratio0.590.9264%
Fund Existence9 years8 years-
Gain YTD5.6022.022277%
Front LoadN/AN/A-
Min. Initial Investment02500000-
Min. Initial Investment IRAN/AN/A-
Net Assets33B941M3,507%
Annual Yield % from dividends0.180.00-
Returns for 1 year3.771.73218%
Returns for 3 years57.3340.47142%
Returns for 5 years51.108.43606%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLSS0.47N/A
-0.97%
Milestone Scientific
KKR135.66-2.28
-1.65%
KKR & Co
RNA40.84-2.37
-5.48%
Avidity Biosciences
NMRA1.70-0.13
-7.10%
Neumora Therapeutics
PGEN3.48-0.37
-9.72%
Precigen